 BOSTON, Oct. 30, 2020 GLOBE NEWSWIRE -- Aprea Therapeutics, Inc. Nasdaq: APRE, a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics to reactivate mutant tumor suppressor protein, p53, will host a live virtual RD Day Webinar, with presentations by key opinion leaders in hematology, today from 1:00 3:00 pm Eastern Time. 